TickerTalks
Browse all tickers →
TickerTalks›$HUM
HUHUM

Humana Inc.

$HUM·$44B·Medical - Healthcare Plans·Healthcare
$363.72-0.8%YTD+43.2%1Y+45.6%
Mentions · last 7 days
2026-07-25: 2 posts2026-07-26: 5 posts2026-07-27: 9 posts2026-07-28: 26 posts2026-07-29: 134 posts2026-07-30: 25 posts2026-07-31: 13 posts214
Price updated 5h ago·X counts updated 3h ago
HUHUM
$HUMHumana Inc.
$363.72-0.80%214 posts
AI analysisFundamentalsVoices on X
Loading…

Sentiment on XAI analysisGenerated by AI from underlying data

Top X posts

How loud the X conversation is around $HUM and which way it's leaning — read in seconds.

X sentiment

What the X crowd is saying right now — descriptive, summarised from the day’s posts.

Mixed sentiment⚠12 posts analyzed · as of 2026-07-31 · top-engagement diverged

Humana's Q2 beat but the stock sold off. EPS $7.61 vs $7.25 consensus, MLR 91.2% vs 91.4%, Centerwell revenue $6.8B vs $6.4B, and management maintained FY26 EPS guidance of at least $9.00. Bulls point to Evercore ISI upgrading to Outperform with a $480 PT on Stars recovery driving 2028 upside. But the tape called it 'HUM getting smoked on earnings, death, taxes and this,' and the stock printed -6% pre-market. The debate is genuine even with the beat.

Read what X is saying about $HUM

  • Bullish vs bearish call — with the AI summary of the day's posts
  • Divergence flag when the top-engagement posts argue the other side
  • Volume context so you know if today's chatter is normal or unusual
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.

Industry overviewAI analysisGenerated by AI from underlying data

Where Medical - Healthcare Plans sits in its cycle right now — and what that implies for $HUM.

Medical - Healthcare Plans · Healthcare

No material change from last week — Oscar Health's AI-driven clinical platform is gaining member growth while the UNH Medicaid fraud litigation adds regulatory risk to legacy insurers.

Top industry ETF

$IHFiShares U.S. Healthcare Providers ETF
+18.2%YTD
+35.4%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
34.4How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
4.5%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
1.4%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
-1.0%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
0.3Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
6.9%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
13.7%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.7Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Jul 29, 2026$7.61$7.27+4.7%
Q1 2026Apr 29, 2026$10.31$10.24+0.7%
Q4 2025Feb 11, 2026$-3.96$-4.00+1.0%
Q3 2025Nov 5, 2025$3.24$2.93+10.6%
Next earningsWed, Nov 4·consensus EPS $-0.84

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$40.9B+26.2%13.5%3.3%$5.79$-558.0M
Q1 FY26$39.6B+23.5%15.0%4.0%$9.85$1.1B
Q4 FY25$32.5B+11.3%11.7%-3.2%$-6.61$-1.9B
Q3 FY25$32.6B+11.1%14.3%0.3%$1.62$836.0M

Forward consensus

5-year forecast · up to 17 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$162.3B$160.7B – $164.8B$8.99$8.18 – $11.1815
FY27$168.8B$159.6B – $184.4B$16.28$13.39 – $20.7117
FY28$178.4B$161.3B – $198.6B$27.04$19.97 – $32.1016
FY29$184.0B$174.7B – $195.8B$34.68$32.41 – $37.5815
FY30$203.0B$192.7B – $216.0B$35.72$33.37 – $38.7015

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.1.5×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.77%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.+0.0%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+38.5%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatMid float · 119.8M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today2.0% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.725-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

BuyFeb 23Sanjay K ShettyPresident810 sh$150K
+ 28 other (13 awards · 7 exempts · 7 inkinds · 1 other) in window

See when $HUM insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Medicare Advantage Insurers Are Redrawing the Map for 2027. Members Find Out by Letter This Fall.247wallst.com·14h agoHere Are Wednesday’s Top Wall Street Analyst Research Calls: Bloom Energy, Dave, Fiverr, Humana, Las Vegas Sands, Lemonade, Procter & Gamble, SK hynix, Wix.com, and More247wallst.com·2d agoThis Humana Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursdaybenzinga.com·2d agoHumana Q2 Earnings Call Highlightsmarketbeat.com·2d agoHumana Q2 Earnings Review: Management Tight-Lipped, But Recovery Still On Trackseekingalpha.com·2d ago

More in Medical - Healthcare Plans

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$UNH$OSCR$CNC$CVS$CLOV$CI$ALHC$MOH
Voices on X · top 12 · last 7 days

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport